Taiwan - Delayed Quote TWD

Taiwan Mask Corporation (2338.TW)

32.00
-0.35
(-1.08%)
At close: 1:30:02 PM GMT+8
Loading Chart for 2338.TW
  • Previous Close 32.35
  • Open 32.45
  • Bid 32.00 x --
  • Ask 32.05 x --
  • Day's Range 31.45 - 32.45
  • 52 Week Range 27.90 - 85.20
  • Volume 1,021,383
  • Avg. Volume 1,213,331
  • Market Cap (intraday) 6.598B
  • Beta (5Y Monthly) 1.38
  • PE Ratio (TTM) --
  • EPS (TTM) -2.21
  • Earnings Date --
  • Forward Dividend & Yield 1.50 (4.64%)
  • Ex-Dividend Date Sep 2, 2024
  • 1y Target Est --

Taiwan Mask Corporation engages in the research, development, manufacturing, and sales of photomasks and integrated circuits for the semiconductor industry. The company provides technology assistance, consultation, inspection, and repair services; precious metal coating; 3D printing and plastic mold design; and packaging and testing services. In addition, it manufactures and sells medical equipment; power component design; and distributes electronic materials and precision equipment, as well as engages in retail and wholesale of medical equipment. It has operations in Taiwan, Asia, and internationally. Taiwan Mask Corporation was incorporated in 1988 and is headquartered in Hsinchu City, Taiwan.

www.tmcnet.com.tw

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 2338.TW

View More

Performance Overview: 2338.TW

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

2338.TW
35.03%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
5.66%

1-Year Return

2338.TW
52.17%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
2.76%

3-Year Return

2338.TW
57.14%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
37.25%

5-Year Return

2338.TW
35.51%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
100.93%

Compare To: 2338.TW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2338.TW

View More

Valuation Measures

As of 5/14/2025
  • Market Cap

    6.67B

  • Enterprise Value

    16.49B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.91

  • Price/Book (mrq)

    1.52

  • Enterprise Value/Revenue

    2.18

  • Enterprise Value/EBITDA

    15.63

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -6.25%

  • Return on Assets (ttm)

    0.66%

  • Return on Equity (ttm)

    -17.12%

  • Revenue (ttm)

    7.56B

  • Net Income Avi to Common (ttm)

    -472.52M

  • Diluted EPS (ttm)

    -2.21

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.64B

  • Total Debt/Equity (mrq)

    357.62%

  • Levered Free Cash Flow (ttm)

    -533.74M

Research Analysis: 2338.TW

View More

People Also Watch